MTIP announces first closing of second fund at EUR130 million

MTIP FUND II, SCSp is MTIP’s second healthtech fund, invests in digital health and connected medical device companies, based primarily in Europe, that offer differentiated solutions for a rapidly evolving healthcare environment. The capital for MTIP FUND II was raised by different investors comprising mainly institutional investors, pension funds, family offices, hospitals, and foundations. The company is especially proud to work together with the European Investment Fund (EIF) as an anchor investor.

EIF’s Chief Executive Alain Godard said: “With a market estimated to continuous growing, healthtech is at the center of major on-going and upcoming innovations. MTIP’s fund strategy fits with EIF’s ambition of financing the vital growth segment of the European Venture Capital ecosystem, which is largely underfunded and overly dependent on non-European investors for larger investments. The EIF is pleased to support MTIP and tackle two major gaps in the European market – digital health and growth capital.”

Three investments executed

MTIP is the first pure play pan-European healthtech investor and has already executed three investments with its newest fund. The first investment was carried out in Oviva, a digital nutritional therapy platform headquartered in Switzerland that offers both face-to-face sessions and remote support for clients from dietitians via smartphone app. The second one in Trialbee, a digital platform for patient recruitment and retention for clinical trials based in Sweden. And finally, Barcelona-based Koa Health, that delivers mental health support that adapts to individuals’ unique circumstances. The Fund continues to see a unique flow of new investment opportunities, enhanced by the firm’s extensive network, its leading role in Europe, and the strength of its strategy.

“This closing is an enormously important milestone in our company history, and we are particularly pleased to have overachieved our expectations – even during a pandemic. Our Fund II has already added three stellar investments to its portfolio with more to come in the near future. This creates a strong momentum towards the final close”, emphasizes Christoph Kausch, Managing Partner of MTIP. “We are pleased to have onboarded existing investors as well as new limited partners for the first closing of our newest Fund and are grateful for the support and confidence they have shown towards our investment strategy and our mission to empower innovation that improves lives”, he continues.